Suppr超能文献

参与NADPH氧化酶激活的Rac效应子特异性结构域的表征。

Characterization of the effector-specifying domain of Rac involved in NADPH oxidase activation.

作者信息

Kwong C H, Adams A G, Leto T L

机构信息

Laboratory of Host Defenses, NIAID, National Institutes of Health, Bethesda, Maryland 20892, USA.

出版信息

J Biol Chem. 1995 Aug 25;270(34):19868-72. doi: 10.1074/jbc.270.34.19868.

Abstract

Production of microbicidal oxidants by phagocytic leukocytes requires activation of a latent NADPH oxidase by the coordinated assembly of a membrane-associated flavocytochrome b558, with three cytosolic components, p47phox, p67phox, and the low molecular weight GTP-binding protein Rac. Rac1 and Rac2 have 92% sequence identity and are both active in supporting the oxidase, while CDC42Hs, the closest relative to Rac with 70% sequence identity, only weakly supports oxidase activation in vitro. We have used CDC42Hs as a foil to identify residues in Rac that are critical for oxidase activation. Most of the divergent sequences of CDC42Hs could be incorporated into Rac-CDC42Hs chimeric proteins without affecting cell-free NADPH oxidase activity. However, incorporation of the amino-terminal segment of CDC42Hs (residues 1-40), which differs from Rac1 by only four residues (positions 3, 27, 30, and 33), resulted in a marked loss of oxidase activation capacity. Point mutagenesis studies showed that this was due to changes at residues 27 and 30, but not residues 3 and 33. Conversely, incorporation of the amino terminus of Rac1 (residues 1-40) into CDC42Hs increased its activity to that of Rac1, indicating that this terminus contains the effector-specifying domain of Rac. Taken together, these studies show that the difference in the activity between CDC42Hs and Rac1 is due entirely to differences in amino acids at position 27 and 30.

摘要

吞噬性白细胞产生杀菌性氧化剂需要通过膜相关黄素细胞色素b558与三种胞质成分p47phox、p67phox和低分子量GTP结合蛋白Rac的协同组装来激活潜在的NADPH氧化酶。Rac1和Rac2具有92%的序列同一性,并且在支持氧化酶方面均具有活性,而与Rac序列同一性为70%的最近亲属CDC42Hs在体外仅微弱支持氧化酶激活。我们利用CDC42Hs作为对照来鉴定Rac中对氧化酶激活至关重要的残基。CDC42Hs的大多数不同序列可以掺入Rac-CDC42Hs嵌合蛋白中而不影响无细胞NADPH氧化酶活性。然而,掺入CDC42Hs的氨基末端片段(第1至40位残基),其与Rac1仅在四个残基(第3、27、30和33位)上不同,导致氧化酶激活能力显著丧失。点突变研究表明,这是由于第27和30位残基的变化,而不是第3和33位残基的变化。相反,将Rac1的氨基末端(第1至40位残基)掺入CDC42Hs可将其活性提高到Rac1的水平,表明该末端包含Rac的效应物特异性结构域。综上所述,这些研究表明CDC42Hs和Rac1之间活性的差异完全是由于第27和30位氨基酸的差异。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验